AI-informed virtual assistant to help solve ‘stubborn problems,’ says Saama

By Melissa Fassbender contact

- Last updated on GMT

DaLIA is Saama’s new Deep Learning Intelligent Assistant. (Image: Getty/metamorworks)
DaLIA is Saama’s new Deep Learning Intelligent Assistant. (Image: Getty/metamorworks)
Saama has launched a set of artificial intelligence (AI) capabilities designed to understand "typical life science domain questions" to better support clinical trial planning, feasibility, and conduct.

The new “deep learning intelligent assistant” – DaLIA – leverages natural language processing (NLP) and natural language understanding (NLU) to enhance Saama’s ​existing suite of clinical trial solutions, according to the company. The so-called virtual assistant is an alternative to the keyboard and mouse.

“DaLIA is not only the gateway to robust conversational experiences with clinical trial data but the gateway to key AI enabled functionality within Saama’s Life Science Analytics Cloud (LSAC),”​ said Malaikannan Sankarasubbu, VP of AI Research, Saama Technologies.

The company’s LSAC is designed to address challenges including trial feasibility and planning, study conduct, as well as preclinical operations, such as adverse drug event and drug-drug interactions.

“DaLIA is domain and context aware which is significant,”​ Sankarasubbu told us. “DaLIA will keep track of the conversation you are having with it so that you can ask subtending questions without having to prefix it for context. DaLIA is designed to understand typical life science domain questions.”

Saama is currently piloting DaLIA at multiple pharmaceutical customers and will continue to implement the technology throughout 2018.

Sankarasubbu said: “Saama does not believe in using AI for the sake of using AI. Saama’s use of AI is focused and targeted at solving stubborn problems the industry has had for years.”

Related news

Show more

Related products

show more

Next generation ePRO from SQN Health

Next generation ePRO from SQN Health

In an era of rapid technology growth, healthcare requires low cost solutions for real-time data collection. We have come a long way from paper to EDC and...

baxter_bloomington_facility_larger

Sterile Injectables Contract Manufacturing

Baxter BioPharma Solutions | 02-Apr-2018 | Product Brochure

Baxter BioPharma Solutions' award-winning facility in Bloomington, Indiana, USA, is a leader in sterile contract manufacturing of injectable products.

lyo_development

Lyophilization Scale-Up and Tech Transfer

Baxter BioPharma Solutions | 12-Mar-2018 | Technical / White Paper

There are few challenges when increasing the scale of production for a solution formulation, but the challenges drastically increase when the formulation...

Related suppliers

Follow us

Products

View more